XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenue, net
Operating expenses:        
Research and development 180,297 224,260 377,736 558,148
General and administrative 1,740,803 2,308,075 3,387,416 4,291,987
Total operating expenses 1,921,100 2,532,335 3,765,152 4,850,135
Loss from operations (1,921,100) (2,532,335) (3,765,152) (4,850,135)
Other income (expense)        
Other (expense) income (Note 14) (994,712) 40,079 (975,688) 76,871
FMV adjustment on contingent stock & warrants 822,130 (90,108) 1,672,187 93,977
Foreign currency (8,645) (23,461) (16,060) (38,368)
Total Other Income (Expense) (181,227) (73,490) 680,439 132,480
Net Loss $ (2,102,327) $ (2,605,825) $ (3,084,713) $ (4,717,655)
Net loss per share, basic $ (0.10) $ 0.22 $ (0.15) $ (0.42)
Net loss per share, diluted $ (0.10) $ 0.22 $ (0.15) $ (0.42)
Weighted average shares used to compute net loss per share, basic 21,557,563 11,655,936 20,106,750 11,193,740
Weighted average shares used to compute net loss per share, diluted 21,557,563 11,655,936 20,106,750 11,193,740